Advertisement

Topics

ValiRx Company Profile

09:07 EDT 22nd June 2018 | BioPortfolio

ValiRx Plc is a biopharmaceutical company developing novel technologies and products in oncology therapeutics and diagnostics. The product focus is in the epigenomic analysis and treatment of cancer, but the technologies can be applied to other fields as well, such as neurology and inflammatory diseases.

Location

24 Greville Steet
London
EC1N 8SS
United Kingdom

Contact

Phone: +44 (0)203 0084416
Fax: +44 (0)203 0084415


News Articles [28 Associated News Articles listed on BioPortfolio]

ValiRx: Bioscience Innovation

In this interview, filmed during BioEurope 2008 in Madrid, Fintan Walton speaks with Satu Vainikka, CEO of ValiRx, an AIM listed biopharmaceutical company based in the UK. Focusing on epigenetics, Val...

ValiRx puts convertible loan note facility with Yorkville to bed

ValiRx confirms that there are no further obligations existing between itself and Yorkville

How are ValiRx developing personalised medicines for the treatment of cancer?

If you experience problems with the audio on this interview please use mp4 link. bit.ly/1wQTjzx Overzealous, rebellious or inappropriate activity by specific genes contributes to many diseases stat...

ValiRx gets US patent for VAL201 compound

Clinical stage biotechnology company ValiRx announced on Tuesday that the US patent and trademark office has granted the patent application 14/575065 (Anti-Androgen Peptides and Uses Thereof in Can...

ValiRx surges as it continues “advanced conversations” with possible partners for lung cancer drug

ValiRx released the positive results of a phase II trial of its lead drug earlier this year and it is now looking for a partner to help take VAL401 through a phase III study and into the market

ValiRx granted crucial EU patent for VAL201

(WebFG News) - Clinical stage biotechnology company ValiRx announced on Wednesday that the European Union patent and trademark office has granted EU Patent Application 08717866.1 - Anti-Androgen Pe...

ValiRx continues “advanced conversations” with possible partners for VAL401 lung cancer drug

ValiRx released the positive results of a phase II trial of its lead drug earlier this year and it is now looking for a partner to help take VAL401 through a phase III study and into the market

ValiRx rockets on 'increased confidence' in lung cancer trials

Clinical stage biotechnology company ValiRx has completed data collection from a recent Phase II trial on its lung cancer treatment and is now taking steps towards completing a clinical study repor...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

ValiRx

ValiRx Plc is a biopharmaceutical company developing novel technologies and products in oncology therapeutics and diagnostics. The product focus is in the epigenomic analysis and treatment of cancer, ...

More Information about "ValiRx" on BioPortfolio

We have published hundreds of ValiRx news stories on BioPortfolio along with dozens of ValiRx Clinical Trials and PubMed Articles about ValiRx for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ValiRx Companies in our database. You can also find out about relevant ValiRx Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record